These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10418851)

  • 1. Cellular mechanisms of insulin resistance in humans.
    Shulman GI
    Am J Cardiol; 1999 Jul; 84(1A):3J-10J. PubMed ID: 10418851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus.
    Petersen KF; Shulman GI
    Am J Cardiol; 2002 Sep; 90(5A):11G-18G. PubMed ID: 12231074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of troglitazone action in type 2 diabetes.
    Petersen KF; Krssak M; Inzucchi S; Cline GW; Dufour S; Shulman GI
    Diabetes; 2000 May; 49(5):827-31. PubMed ID: 10905493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.
    Shulman GI; Rothman DL; Jue T; Stein P; DeFronzo RA; Shulman RG
    N Engl J Med; 1990 Jan; 322(4):223-8. PubMed ID: 2403659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus.
    Rothman DL; Magnusson I; Cline G; Gerard D; Kahn CR; Shulman RG; Shulman GI
    Proc Natl Acad Sci U S A; 1995 Feb; 92(4):983-7. PubMed ID: 7862678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes.
    Cline GW; Petersen KF; Krssak M; Shen J; Hundal RS; Trajanoski Z; Inzucchi S; Dresner A; Rothman DL; Shulman GI
    N Engl J Med; 1999 Jul; 341(4):240-6. PubMed ID: 10413736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of NMR spectroscopy to study muscle glycogen metabolism in man.
    Roden M; Shulman GI
    Annu Rev Med; 1999; 50():277-90. PubMed ID: 10073278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin action and substrate competition.
    Groop LC; Ferrannini E
    Baillieres Clin Endocrinol Metab; 1993 Oct; 7(4):1007-32. PubMed ID: 8304911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular mechanism of insulin resistance: potential links with inflammation.
    Perseghin G; Petersen K; Shulman GI
    Int J Obes Relat Metab Disord; 2003 Dec; 27 Suppl 3():S6-11. PubMed ID: 14704736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Effects of Metformin in Humans.
    Adeva-Andany MM; Rañal-Muíño E; Fernández-Fernández C; Pazos-García C; Vila-Altesor M
    Curr Diabetes Rev; 2019; 15(4):328-339. PubMed ID: 30306875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction.
    Boden G; Shulman GI
    Eur J Clin Invest; 2002 Jun; 32 Suppl 3():14-23. PubMed ID: 12028371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free fatty acids, insulin resistance, and type 2 diabetes mellitus.
    Boden G
    Proc Assoc Am Physicians; 1999; 111(3):241-8. PubMed ID: 10354364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects.
    Perseghin G; Price TB; Petersen KF; Roden M; Cline GW; Gerow K; Rothman DL; Shulman GI
    N Engl J Med; 1996 Oct; 335(18):1357-62. PubMed ID: 8857019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus.
    Rothman DL; Shulman RG; Shulman GI
    J Clin Invest; 1992 Apr; 89(4):1069-75. PubMed ID: 1556176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism.
    Vestergaard H
    Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction.
    Morino K; Petersen KF; Shulman GI
    Diabetes; 2006 Dec; 55 Suppl 2(Suppl 2):S9-S15. PubMed ID: 17130651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear magnetic resonance studies of hepatic glucose metabolism in humans.
    Roden M; Petersen KF; Shulman GI
    Recent Prog Horm Res; 2001; 56():219-37. PubMed ID: 11237214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free fatty acids-the link between obesity and insulin resistance.
    Boden G
    Endocr Pract; 2001; 7(1):44-51. PubMed ID: 11250769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms.
    Wiernsperger NF; Bailey CJ
    Drugs; 1999; 58 Suppl 1():31-9; discussion 75-82. PubMed ID: 10576523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.